Primary study · included by 1 review
Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long‐term study
Le Roux 2020 · Le Roux Marc‐Kevin, Graillon Nicolas, Guyot Laurent, et al. · Head & Neck · 2020
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Xerostomia (pooled prevalence) Radioiodine (I131) therapy · within 2 months after RIT | Prevalence 0.60 [0.28, 0.85] | 3 studies · 1502 participants | GRADE not reported |
1 including review in total.